| 研究生: |
游佩雯 Yu, Pei-wen |
|---|---|
| 論文名稱: |
藥師對繼續教育課程需求之探討 Assessment of Pharmacists’ Needs about the Subjects of Continuing Pharmacy Education |
| 指導教授: |
高雅慧
Yang, Yea-Huei Kao |
| 學位類別: |
碩士 Master |
| 系所名稱: |
醫學院 - 臨床藥學研究所 Institute of Clinical Pharmacy |
| 論文出版年: | 2009 |
| 畢業學年度: | 97 |
| 語文別: | 中文 |
| 論文頁數: | 114 |
| 中文關鍵詞: | 藥師 、繼續教育 、藥師繼續教育 |
| 外文關鍵詞: | Continuing education, pharmacists, CPE |
| 相關次數: | 點閱:159 下載:5 |
| 分享至: |
| 查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
【研究背景】
由於醫學及藥物發展之日新月異,因此,欲成為一位專業藥師,除了經過國家考試的認定,在之後的職業生涯仍需不斷地增進自己的專業知識,因此,繼續教育是不可或缺的機制。在我國,民國九十六年新修訂的《藥師法》規定︰「每六年提出完成繼續教育證明文件,辦理執業執照更新。」衛生署繼而於民國九十七年十二月底,依據藥師法公告《藥師執業登記及繼續教育辦法》草案,對於藥師繼續教育之法定要求開啟新的發展,原先施行數年的《全民健康保險特約醫事服務機構藥事人員繼續教育認定要點》所規範之「健保特約藥事人員」轉變為所有的「執業藥師」,除了範圍的擴大之外,同時也形成了強制性。因此,可以想見我國藥師對於繼續教育之需求將大為增加。
根據過去我國相關藥師繼續教育的研究中,顯示了不同執業領域的藥師對繼續教育課程確有「量身訂做」的需求;但是,針對課程內容需求之研究則屬闕如。因此,藥師之執業環境類型與繼續教育課程內容之相關性是亟待探討的議題。
【研究目的】
探討藥師之執業環境類型與繼續教育課程內容需求之相關性,並比較在藥師需求面與制度面的差異。
【研究方法】
本研究為橫斷式研究,以網路問卷進行調查。
以執業藥師為研究對象,採公開徵求受訪者的方式來進行收樣,過程中利用藥師週刊的廣告與藉由台灣藥學相關網站來宣傳,以邀請藥師前往問卷網站進行問卷之填寫,隨後再由回傳的資料庫來進行分析。
【研究結果】
排除重複與無效資料後,共有 486位藥師完成問卷。共 197位男性與 289位女性藥師,而在執業類型的分布,共有醫院藥師 257位、社區藥局藥師114位、診所藥師 53位、藥業藥師 25位、其餘執業類型藥師 37位。而在年齡層以50歲以下佔 89.9%,學士學歷藥師佔 63.6%。
經過分析後,執業類型在藥師對繼續教育課程需求之影響最廣,調查的 41項課程中有21項會因藥師執業類型的不同而有差異。而性別、年齡、職業年資、最高學歷則僅在部份的課程有影響。此外,有 91.2%藥師認同應依不同執業類型而有不同必修課程要求,結果間具一致性。而藥師對非講授式課程的時數限制則有較低同意度。
藥師認為最理想的繼續教育形式為講授式課程,其次為網路繼續教育。而整體影響藥師選擇繼續教育最大的因素為繼續教育費用;而在社區藥局與藥業藥師影響選擇繼續教育最大的因素則為執業必需。
【結論】
在本研究中,藥師對課程之需求強烈反應了其在執業上的需要,而藥師亦認同應對不同的執業類型有不同必修課程要求,顯示針對藥師的執業需求來設計繼續教育的課程是合理且必要的,尤其在社區藥局與藥業藥師。繼續教育提供者應依不同的聽眾來設計課程,繼續教育審查單位也應針對此把關,而在我國藥政也應審視法規面與藥師需求的不一致處並考慮調整。
[Background]
Maintaining competence throughout their careers is a lifelong challenge for all health care professionals, including pharmacists. To maintain up-to-date professional competency, continuing education is indispensable.
Not until 2007, the mandatory CPE (Continuing Pharmacy Education) was limited to the NHI contracted pharmacy-practitioners in Taiwan. Because, the Pharmacists’ Act was amended in March 2007, which had expanded mandatory CPE from pharmacy-practitioners in the NHI contracted medical care services to every practicing pharmacist. Therefore, increasing needs for CPE can be expected under the rule in Pharmacists’ Act. Recently, draft regulations governing the registration of practice and continuing education for pharmacists was announced in December 2008. Besides, the studies related to CPE in Taiwan revealed that pharmacists had the customization need to subjects of the continuing education for different practice settings. However, the needs are unclear.
[Objectives]
To investigate pharmacists’ needs related to CPE in Taiwan, this study aimed to:
1. Compare the regulations of CPE with the pharmacists’ needs for CPE; and
2. Assess the needs about the subjects of CPE for different practice practices.
[Methods]
This was a cross-sectional study. The pharmacists in Taiwan were surveyed by a Web questionnaire during March 31 and May 15 in 2009. We advertised the study on pharmacy-related websites and the "Pharmacist Weekly" in order to invite volunteer pharmacists to the homepage of the Web questionnaire.
[Results]
After excluded duplicated and invalid data, 486 pharmacists filled the Web questionnaire. There were 197 male and 289 female pharmacists. The number of the pharmacists from hospital, community, clinic, industry, and other settings were 257, 114, 53, 25, and 37, respectively. Furthermore, most of the participants were graduated with bachelor degree and younger than 51 years old.
The practice setting was found to be the most significant factor to the needs about the subjects of CPE. Among the 41 CPE subjects, 21 were found to be significantly associated with the practice setting as examined by multivariate analysis. The other variables including, gender, age, literature, or period of practice only had partial correlation with the needs. Additionally, 91.2% pharmacists agreed with "Mandatory CPE should be designated based on various practice settings". The results were consistent.
In the methods of delivery, pharmacists were most preferred to the live lecture. The most effective determinant for CPE is cost. Other determinants had various effects in different practice settings. By the way, the practice related need had the highest correlation in community and industrial pharmacists.
[Conclusion]
Pharmacists do have various needs about the subjects of CPE in different practice settings. CPE providers should design the subjects of continuing education for the audience from different practice settings, and the pharmacy associations for the accreditation of CPE should also pay attention to the design of each CPE program. Finally, the national organization should consider if any inappropriateness in the regulation of CPE.
1. 《藥師法》 總統華總一義字第 09600035241 號令修正 (中華民國, 2007).
2. 行政院衛生署 《藥師執業登記及繼續教育辦法》草案總說明, 衛署藥字第0970330170號 (行政院公報, 中華民國, 2008), Vol. 249, pp. 36708-36717.
3. 行政院衛生署 《全民健康保險特約醫事服務機構藥事人員繼續教育認定要點》 衛署藥字第0920321353號修正 (中華民國, 2003).
4. 黃婉翠, 許光陽, 陳香吟, 對社區藥局藥師進行持續教育成效及經營現況之互動探討. 台北醫學院, 藥學研究所 (2002).
5. 陳佩玉, 溫燕霞, 我國藥師專業執業繼續教育現況之探討. 高雄醫學大學, 藥學研究所碩士在職專班 (2004).
6. Accreditation Council for Pharmacy Education (ACPE), Accreditation Standards for Continuing Pharmacy Education, (2007). Accessed Nov 10, 2008, at http://www.acpe-accredit.org/pdf/CPE_Standards_Final.pdf.
7. The International Pharmacuetical Federation (FIP), FIP Statement of Professional Standards: Continuing Professional Development. (2002).
8. Vlasses, P.H., Pharmacy continuing education: 40 years ago to now. Ann Pharmacother 40 (10), 1854-1856 (2006).
9. Riley, D.A., Continuing education issues relating to pharmacists' morale: Demographic implications for programmers. J Contin Educ Health Prof 8 (3), 167-179 (1988).
10. Argus-Commission, Roadmap to 2015: Preparing Competent Pharmacists and Pharmacy Faculty for the Future. Am J Pharm Educ 70 (S5), 1-27 (2006).
11. Rouse, M.J., Continuing professional development in pharmacy. Am J Health-Syst Pharm 61, 2069-2076 (2004).
12. The International Pharmaceutical Federation (FIP), FIP Policy Statement on Good Pharmacy Education Practice. (2000).
13. The International Pharmaceutical Federation (FIP), Global Pharmacy Workforce and Migration Report, (2006). Accessed Mar 9, 2009, at http://www.fip.org/www/index.php?page=rfh_datacollection.
14. Driesen, A., Verbeke, K., Simoens, S., & Laekeman, G., International trends in lifelong learning for pharmacists. Am J Pharm Educ 71 (3), 1-10 (2007).
15. NHS Education for Scotland (NES), Pharmacy Programme 2008-2009, (2008). Accessed Apr 7, 2009, at http://www.nes.scot.nhs.uk/pharmacy/cpd/default.asp.
16. Centre for Pharmacy Postgraduate Education (CPPE), Annual prospectus-Educational solutions for the NHS pharmacy workforce (2008). Accessed Dec 3, 2008, at http://www.cppe.ac.uk/LearningProgrammes/.
17. Royal Pharmaceutical Society of Great Britain (RPSGB), Professional Standards and Guidance for Continuing Professional Development, (2009). Accessed Oct 29, 2008, at http://www.rpsgb.org/protectingthepublic/ethics/#coe.
18. London Pharmacy Education and Training (LPE&T), CPD News, (2009).
Accessed May 2, 2009, at http://www.londonpharmacy.nhs.uk/educationandtraining/cpd/cpdNews.aspx.
19. Accreditation Council for Pharmacy Education (ACPE), ACPE Continuing Pharmacy Education Provider Accreditation Program Policies and Procedures Manual: A Guide for ACPE-accredited Providers, (2008).
Accessed Mar 25, 2009, at http://www.acpeaccredit.org/pdf/CPE_Policies_Procedures_Approved_June_2008.pdf.
20. The Canadian Council on Continuing Education in Pharmacy (CCCEP), Guidelines and Criteria for CCCEP Accreditation, (2008).
21. Canadian Pharmacists Association (CPhA), Continuing Education Centre, (2009). Accessed May 20, 2009, at http://www.pharmacists.ca/function/ws/cevl.cfm.
22. Ontario Colledge of Pharmacists (OCP), Continuing Professional Development, (2008-2009). Accessed May 20, 2009, at http://www.ocpinfo.com/client/ocp/OCPHome.nsf/web/CE+Overview.
23. Pharmaceutical Society of Australia (PSA), Criteria for the accreditation of activities for Continuing Professional Development and Practice Improvement, (2008).
24. Pharmaceutical Society of Australia (PSA), Activities recognised under the CPD&PI program. (2008).
25. 日本薬剤師研修センター, 研修認定薬剤師制度実施要領, (2007). Accessed Oct 29, 2008, at http://www.jpec.or.jp/contents/c03/index.html.
26. 日本薬剤師研修センター, 薬剤師生涯研修の指標項目, (2009). Accessed May 25, 2009, at http://www.jpec.or.jp/contents/c03/top6.html.
27. 大規模生涯研修計画検討委員会, 今後の薬剤師研修のあり方について, (2004). Accessed Oct 29, 2008, at http://www.jpec.or.jp/contents/c24/index.html.
28. 日本薬剤師研修センター, 新カリキュラム対応研修の実施, (2008). Accessed Oct 29, 2008, at http://www.jpec.or.jp/.
29. 臺灣臨床藥學會, 台灣藥學會, 《藥學會接受中央衛生主管機關委託辦理繼續教育之審核原則》, (2008).
30. The International Pharmaceutical Federation (FIP), 2020 vision-FIP’s vision, mission and strategic plan. (2008).
31. Hanson, A.L., Pharmacists’ Attitudes Toward Continuing Education: Implications for Planning Curricular CE Programs. Journal of Continuing Education in the Health Professions 9 (2), 95-113 (1989).
32. Hanson, A.L., Bruskiewitz, R.H., & Demuth, J.E., Pharmacists' perceptions of facilitators and barriers to lifelong learning. Am J Pharm Educ 71 (4), 67 (2007).
33. Power, A. et al., Scottish pharmacists' views and attitudes towards continuing professional development. Pharm World Sci 30 (1), 136-143 (2008).
34. Scott, V.G., Amonkar, M.M., & Madhavan, S.S., Pharmacists' preferences for continuing education and certificate programs. Ann Pharmacother 35 (3), 289-299 (2001).
35. Cordero, L. et al., Continuing education and community pharmacists in Galicia: a study of opinions. Pharm World Sci 26 (3), 173-177 (2004).
36. Namara, K.P., Duncan, G.J., McDowell, J., & Marriott, J.L., Community pharmacists' preferences for continuing education delivery in Australia. J Contin Educ Health Prof 29 (1), 52-57 (2009).
37. 黃婉翠, 林惜燕, 姜易醇, 林英琦, 陳香吟, 對社區藥局藥師進行持續教育成效之探討. 台灣臨床藥學雜誌 11 (2), 33-54 (2003).
38. 高雅慧, 趙子揚, 廖欣儀, 林建甫, 黃暉竣, 藥事人員繼續教育現況分析與線上學習之探討 九十七年度行政院衛生署補助研究計畫 (2008).
39. TWNIC, 歷次個人及家庭上網行為調查趨勢分析, (2009). Accessed Mar 12, 2009, at http://www.twnic.net.tw/download/200307/0901d.pdf.
40. 梁德馨, TWNIC 2009年1月「台灣寬頻網路使用調查」報告, (2009). Accessed Jan 8, 2009, at http://www.twnic.net.tw/download/200307/200307index.shtml.
41. 陳建名, 統計調查規劃設計-網路問卷設計, (2006). Accessed Jan 8, 2009, at http://ebas1.ebas.gov.tw/data/school/95/95B211-C0804.doc.
42. Aiken, L.R., Content Validity and Reliability of Single Items or Questionnaires. Educ Psy Measure 40 (4), 955-959 (1980).
43. Baker, R.P., Crawford, S., & Swinehart, J., Development and Testing of Web Questionnaires in Methods for Testing and Evaluating Survey Questionnaires, edited by Stanley Presser et al. (John Wiley & Sons, Inc., New Jersey, 2004), pp. 361-384.
44. 關秉寅, 信度與效度, (2007). Accessed Feb 25, 2009, at http://www3.nccu.edu.tw/~soci1005/methods.htm.
45. Bartlett, J.E., Kotrlik, J.W., & Higgins, C.C., Organizational Research: Determining Appropriate Sample Size in Survey Research. Inform Tech, Learn Perform J 19 (1), 43-50 (2001).
46. Sample Size Calculator, (2007-2009), Accessed Apr 14, 2009, at http://www.surveysystem.com/sscalc.htm.
47. Raosoft, Sample size calculator, (2004). Accessed Apr 14, 2009, at http://www.ezsurvey.com/samplesize.html.
48. 行政院衛生署, 藥政管理月報, (2008), Accessed May 15, 2009, at http://www.doh.gov.tw/CHT2006/DM/DM2_2.aspx?now_fod_list_no=10162&class_no=440&level_no=3.
49. 史倩玲 「學生上藥局,3成以上為孕事」 立報 (2008).
50. 葉明功 「醫院藥師教育之我思」 藥師週刊 (中華民國藥師公會全聯會, (2007), Vol. 1540.
51. The International Pharmaceutical Federation (FIP), Standards for Quality of Pharmaceutical Services-Good Pharmacy Practice, (2004).
52. 行政院衛生署 《醫師執業登記及繼續教育辦法》 衛署醫字第 0970200995 號令修正 (中華民國, 2008).
53. 行政院衛生署 《護理人員執業登記及繼續教育辦法》 衛署醫字第 0970201020 號令訂定發布 (中華民國, 2008).
54. McDonough, A.K., Curtis, J.R., & Saag, K.G., The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol 20 (2), 131-137 (2008).
55. Buzdar, A. et al., Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate. J Clin Oncol 19 (14), 3357-3366 (2001).
56. Chang, S.J., Chiang, I.N., & Yu, H.J., The effectiveness of tamsulosin in treating women with voiding difficulty. Int J Urol 15 (11), 981-985 (2008).
57. Leaf, D.E. & Goldfarb, D.S., Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol 102 (4), 1313-1322 (2007).